BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• 

  Drug Development

  Hope and Confusion for Huntington’s Patients as PTC, UniQure Report New Data

  The Huntington’s disease space saw a flurry of activity Wednesday as PTC and uniQure released data from their respective mid-phase trials.

  June 21, 2023

   · 

  3 min read

   · 

  Heather McKenzie
• 

  Policy

  PhRMA Joins Merck, BMS in Latest Lawsuit Challenging IRA’s Drug Price Negotiations

  On the heels of Merck’s and BMS’ lawsuits, the pharma industry’s lobbying group Wednesday filed a complaint in federal court asserting that the price-setting provisions in the Inflation Reduction Act are unconstitutional.

  June 21, 2023

   · 

  2 min read

   · 

  Lisa Munger
• 

  FDA

  Lilly and Boehringer Drugs Approved as New Options for Type 2 Diabetes in Kids

  The FDA has approved Jardiance and Synjardy as the first SGLT-2 inhibitors to treat pediatric Type 2 diabetes, providing a new class of oral medicines.

  June 21, 2023

   · 

  2 min read

   · 

  Tristan Manalac
• 

  FDA

  FDA Approves First Subcutaneous Injectable for Muscle-Weakening Disease

  Argenx’s Vyvgart will now be available in the U.S. as a more convenient subcutaneous formulation 18 months after its first approval.

  June 21, 2023

   · 

  2 min read

   · 

  Kate Goodwin
• 

  Drug Development

  AstraZeneca Halts Phase II Asthma Trial Due to Safety Findings in Toxicology Study

  Pieris Pharmaceuticals announced partner AstraZeneca’s decision to discontinue clinical studies of elarekibep, an inhaled IL-4 receptor alpha inhibitor, based on a non-clinical toxicology study.

  June 21, 2023

   · 

  2 min read

   · 

  Connor Lynch
• 

  Policy

  Novo Cracks Down on Counterfeit, Compounded Semaglutide Products

  Following an FDA warning in May, Novo Nordisk has filed several lawsuits against spas, clinics and pharmacies selling compounded version of semaglutide.

  June 21, 2023

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Business

  Flagship-Backed Empress Therapeutics Launches to Accelerate Small Molecule Development

  The startup launches with $50 million to improve its Chemilogics platform, which is designed to speed up the identification and development of small molecule drug candidates.

  June 21, 2023

   · 

  2 min read

   · 

  Tristan Manalac
• 

  Career Advice

  The Top Biotech Companies in California Hiring Now

  Here are the top biotech companies in California hiring now on BioSpace’s life sciences–focused job board.

  June 21, 2023

   · 

  3 min read

   · 

  Rosemary Scott
• 

  Worried About Productivity? Studies Suggest Taking More Breaks

  For some, increased productivity means taking fewer breaks. But new research suggests the opposite may be true.

  June 21, 2023

   · 

  3 min read

   · 

  Lisa Munger
• 

  Drug Development

  Expanding ALS Trial Eligibility Could Benefit Patients, Therapeutic Progress

  The majority of ALS patients are excluded from clinical trials. Experts say using biomarkers and stratifying trial populations can expand eligibility and provide additional scientific insights.

  June 21, 2023

   · 

  6 min read

   · 

  Heather McKenzie